NIH trial testing hyperimmune intravenous immunoglobulin and remdesivir to treat COVID-19
Credit: NIAID A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the...














